Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
First Claim
Patent Images
1. A compound having the Formula II or a pharmaceutically acceptable salt or prodrug thereof, wherein:
- Ar1 is substituted aryl or substituted heteroaryl, wherein said substituents are selected from the group consisting of halo, C1-C6 haloalkyl, C6-C10 aryl, C4-C7 cycloalkyl, C2-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C6-C10 aryl(C1-C6)alkyl, C6-C10 aryl(C2-C6)alkenyl, C6-C10 aryl(C2-C6)alkynyl, C1-C6 hydroxyalkyl, amino, ureido, cyano, C1-C6 acylamino, hydroxy, thiol, C1-C6 acyloxy, azido, C1-C6 alkoxy and carboxy;
Ar3 is optionally substituted arylalkyl, aryloxy, phenoxymethyl, anilino, benzylamino, benzylideneamino, benzoylamino or Ar2, wherein Ar2 is optionally substituted aryl or optionally substituted heteroaryl, wherein said substituents are selected from the group consisting of halo, C1-C6 haloalkyl, C6-C10 aryl, C4-C7 cycloalkyl, C2-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C6-C10 aryl(C1-C6)alkyl, C6-C10 aryl(C2-C6)alkenyl, C6-C10 aryl(C2-C6)alkynyl, C1-C6 hydroxyalkyl, amino, ureido, cyano, C1-C6 acylamino, hydroxy, thiol, C1-C6 acyloxy, azido, C1-C6 alkoxy and carboxy;
with the provisos that;
(a) when Ar1 is substituted thienyl, then Ar3 is other than phenyl substituted by chloro or trifluoromethyl;
(b) when Ar1 is substituted isoxazolyl, then Ar3 is other than unsubstituted phenyl;
(c) when Ar1 is substituted pyrazolyl, then Ar3 is other than pyridinyl substituted by trifluoromethyl and other than phenyl substituted by trifluoromethyl; and
(d) when Ar1 is substituted pyrrolyl, then Ar3 is other than unsubstituted pyridinyl.
3 Assignments
0 Petitions
Accused Products
Abstract
The present invention is directed to substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs thereof, represented by the Formula I:
wherein Ar1, Ar3, A, B and D are defined herein. The present invention also relates to the discovery that compounds having Formula I are activators of caspases and inducers of apoptosis. Therefore, the activators of caspases and inducers of apoptosis of this invention may be used to induce cell death in a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
116 Citations
12 Claims
-
1. A compound having the Formula II
or a pharmaceutically acceptable salt or prodrug thereof, wherein: -
Ar1 is substituted aryl or substituted heteroaryl, wherein said substituents are selected from the group consisting of halo, C1-C6 haloalkyl, C6-C10 aryl, C4-C7 cycloalkyl, C2-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C6-C10 aryl(C1-C6)alkyl, C6-C10 aryl(C2-C6)alkenyl, C6-C10 aryl(C2-C6)alkynyl, C1-C6 hydroxyalkyl, amino, ureido, cyano, C1-C6 acylamino, hydroxy, thiol, C1-C6 acyloxy, azido, C1-C6 alkoxy and carboxy;
Ar3 is optionally substituted arylalkyl, aryloxy, phenoxymethyl, anilino, benzylamino, benzylideneamino, benzoylamino or Ar2, wherein Ar2 is optionally substituted aryl or optionally substituted heteroaryl, wherein said substituents are selected from the group consisting of halo, C1-C6 haloalkyl, C6-C10 aryl, C4-C7 cycloalkyl, C2-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C6-C10 aryl(C1-C6)alkyl, C6-C10 aryl(C2-C6)alkenyl, C6-C10 aryl(C2-C6)alkynyl, C1-C6 hydroxyalkyl, amino, ureido, cyano, C1-C6 acylamino, hydroxy, thiol, C1-C6 acyloxy, azido, C1-C6 alkoxy and carboxy;
with the provisos that;
(a) when Ar1 is substituted thienyl, then Ar3 is other than phenyl substituted by chloro or trifluoromethyl;
(b) when Ar1 is substituted isoxazolyl, then Ar3 is other than unsubstituted phenyl;
(c) when Ar1 is substituted pyrazolyl, then Ar3 is other than pyridinyl substituted by trifluoromethyl and other than phenyl substituted by trifluoromethyl; and
(d) when Ar1 is substituted pyrrolyl, then Ar3 is other than unsubstituted pyridinyl. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. A compound having the Formula II:
-
or a pharmaceutically acceptable salt or prodrug thereof, wherein;
Ar1 is substituted heteroaryl, wherein said substituents are selected from the group consisting of halo, C1-C6 haloalkyl, C6-C10 aryl, C4-C7 cycloalkyl, C2-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C6-C10 aryl(C1-C6)alkyl, C6-C10 aryl(C2-C6)alkenyl, C6-C10 aryl(C2-C6)alkynyl, C1-C6 hydroxyalkyl, amino, ureido, cyano, C1-C6 acylamino, hydroxy, thiol, C1-C6 acyloxy, azido, C1-C6 alkoxy and carboxy; and
Ar3 is optionally substituted heteroaryl, wherein said substituents are selected from the group consisting of halo, C1-C6 haloalkyl, C6-C10 aryl, C4-C7cycloalkyl, C2-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C6-C10 aryl(C1-C6)alkyl, C6-C10 aryl(C2-C6)alkenyl, C6-C10 aryl(C2-C6 )alkynl, C1-C6 hydroxyalkyl, amino, ureido, cyano, C1-C6 acylamino, hydroxy, thiol, C1-C6 acyloxy, azido, C1-C6 alkoxy and carboxy;
with the provisos that;
(a) when Ar1 is substituted pyrazolyl, then Ar3 is other than pyridinyl substituted by trifluoromethyl; and
(b) when Ar1 is substituted pyrrolyl, then Ar3 is other than unsubstituted pyridinyl. - View Dependent Claims (11, 12)
-
Specification